Skip to content
healthcare.dev

Selarsdi

NDC 51759-708, ustekinumab-aekn, injection, solution, from Teva Pharmaceuticals USA, Inc..

Product NDC
51759-708
Status
Listed
Labeler
Teva Pharmaceuticals USA, Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761343
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51759-708 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • USTEKINUMAB-AEKN130 mg/26mL

Pharmacologic classes

Interleukin-12 Antagonist [EPC]; Interleukin-12 Antagonists [MoA]; Interleukin-23 Antagonist [EPC]; Interleukin-23 Antagonists [MoA]

Package NDCNDC-11Package
51759-708-13517590708131 VIAL, GLASS in 1 CARTON (51759-708-13) / 26 mL in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/87f75b59-e48b-47c7-a4c0-5fe5965660e7
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=51759-708

Use it

Look up 51759-708 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51759-708 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51759-708. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.